Instagram Outage Disrupts Thousands of U.S. Users 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
 Regulatory Submissions, Information and Document Management Forum - EconoTimes)
ROCKVILLE, Md., Feb. 06, 2018 -- Dinocrates Group today announced its CTO, Jim St. Clair, delivered the keynote for the Drug Information Association’s (DIA) Forum on Regulatory Submissions, Information, and Document Management (RSIDM) in Bethesda, Md. St. Clair provided an insider’s perspective about the ways in which blockchain is being piloted for use in the drug information supply chain.
Blockchain has the potential to dramatically improve elements of the pharmaceutical supply chain by helping pharma companies and distributors improve security and traceability to cut down on the spread of counterfeit drugs. With barcode-tagged drugs scanned and entered into secure digital blocks whenever they change hands, an ongoing real-time record can be viewed anytime by authorized parties throughout the supply chain.
St. Clair, who founded the Institute for Healthcare Financial Technology, presented to a packed crowd of regulatory specialists on the use of blockchain to create immutable records of drug information transactions. As part of the presentation, he explained how using blockchain distributed ledgers can help facilitate compliance with the International Standards framework for the Identification of Medicinal Products (IDMP).
St. Clair is leading the effort to establish one of the first blockchain solutions labs for the public and life sciences sectors. The lab, known as ALEXANDER, will host demonstrable solutions and concepts to showcase blockchain applications for industry processes.
About Dinocrates Group
Dinocrates is a boutique strategy and technology advisory firm that is headquartered in Rockville, MD and partners with clients from the public and private sectors to identify their highest-value opportunities, addresses their most critical challenges, and transform their enterprises.
Contact: Ivy Eckerman Spire Communications for Dinocrates Group LLC (540) 373-2963 [email protected]
